Original Research
Published on 10 Feb 2026
Cost-effectiveness of perioperative durvalumab plus FLOT for resectable gastric and gastroesophageal junction adenocarcinoma in the United States
in Cancer Immunity and Immunotherapy
- 168 views
Original Research
Published on 10 Feb 2026
in Cancer Immunity and Immunotherapy
Editorial
Published on 10 Feb 2026
in Aquatic Microbiology
Original Research
Published on 10 Feb 2026
in Aquatic Physiology
Original Research
Published on 10 Feb 2026
in Organizational Psychology
Original Research
Published on 10 Feb 2026
in Family Medicine and Primary Care
Original Research
Published on 10 Feb 2026
in Social and Emotional Development
Review
Published on 10 Feb 2026
in Inflammation
Original Research
Published on 10 Feb 2026
in Gastrointestinal and Hepatic Pharmacology
Review
Published on 10 Feb 2026
in Thoracic Oncology
Brief Research Report
Published on 10 Feb 2026
in Soft Robotics
Original Research
Published on 10 Feb 2026
in Social and Emotional Development
Original Research
Published on 10 Feb 2026
in Neuropsychology
Study Protocol
Published on 10 Feb 2026
in Population Neuroimaging
Original Research
Published on 10 Feb 2026
in Brain Disease Mechanisms
Original Research
Published on 10 Feb 2026
in Renal Endocrinology
Review
Published on 10 Feb 2026
in Inflammation